Company Profile

PAUSHAK LTD.

NSE : NABSE : 532742ISIN CODE : INE111F01016Industry : Chemicals House : Alembic
BSE1796.8566.8 (+3.86 % )
PREV CLOSE (Rs.) 1730.05
OPEN PRICE (Rs.) 1800.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 77
TODAY'S LOW / HIGH (Rs.)1701.00 1800.00
52 WK LOW / HIGH (Rs.) 1301.8 3100
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 1.36992
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 27.93
ROCE (%) 33.73
Incorporation Year : 1972

Management Info :

Chirayu Amin - Chairman - Managing Director

Registered Office :

Address : Alembic Road,,,
Vadodara,
Gujarat-390003

Phone : 0265-2280550 /2280880

Website : www.paushak.com

Registrar's Details : Link Intime India Pvt Ltd.
B-102 & B103, Shangrila Complex, First Floor,Opp: HDFC Bank, Near Radhakrishna Char Rasta,Akota,Vadodara
Listing : BSE
NEWS More
23Jan01-23-2020$ Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Nine Months Period Ended On 31St December, 2019 Board Meeting Intimation fo
PAUSHAK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2020 ,inter alia, to consider and approve With reference to the captioned matter, the Exchange is hereby informed that a Meeting of Board of Directors of the Company shall be held on Friday, the 31st January, 2020, inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December, 2019. Pursuant to the Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st January, 2020 will re-open 48 hours after the declaration of the financial results on 31st January, 2020. We request you to kindly take note of the above.
PAUSHAK LTD.has informed BSE that the meeting of the Board of D..
04Jan01-04-2020$Paushak informs about disclosure Paushak informs about disclo

Paushak has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malika Chirayu Amin.

The above information is a part of company’s filings submitted to BSE.

Paushak has informed that the exchange has received the disclos..
13Dec12-13-2019$Paushak informs about loss of share certificate Paushak informs about loss o

Paushak has informed that the share certificate(s) of the Company has been reported as lost/ misplaced and the shareholder of such lost share certificate(s) has requested the Company for issue of duplicate share certificate(s).

The above information is a part of company’s filings submitted to BSE.

Paushak has informed that the share certificate(s) of the Compa..
04Dec12-04-2019$Paushak receives ‘Responsible Care Logo’ from ICC Paushak receives ‘Responsi

Paushak has received ‘Responsible Care Logo’ from Indian Chemical Council (ICC). Responsible Care is a global initiative of the chemical manufacturing industry that began in Canada in 1984, was enacted by the US chemical industry in 1988, and currently is practiced in 68 economies around the world.

There are 55 enlightened companies having Responsible Care (RC) logo in India, while a total of 148 companies are signatories to the programme, pursuing implementation of Codes of management practice.

Paushak is engaged in the manufacture of Phosgene & its derivatives. Phosgene is a versatile molecule and its derivatives have applications in diverse fields like pharmaceuticals, agrochemicals , polyurethanes, perfumeries, dyes, etc.

Paushak has received ‘Responsible Care Logo’ from Indian Ch..
04Dec12-04-2019$Paushak gains on receiving ‘Responsible Care Logo’ from ICC Paushak gains on receiving â

Paushak is currently trading at Rs. 2460.00, up by 10.00 points or 0.41% from its previous closing of Rs. 2450.00 on the BSE.

The scrip opened at Rs. 2451.50 and has touched a high and low of Rs. 2500.00 and Rs. 2451.50 respectively.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 2870.00 on 01-Nov-2019 and a 52 week low of Rs. 1690.00 on 06-Feb-2019.

Last one week high and low of the scrip stood at Rs. 2560.00 and Rs. 2021.00 respectively. The current market cap of the company is Rs. 755.60 crore.

The promoters holding in the company stood at 66.71%, while Non-Institutions held 33.29% stake.

Paushak has received ‘Responsible Care Logo’ from Indian Chemical Council (ICC). Responsible Care is a global initiative of the chemical manufacturing industry that began in Canada in 1984, was enacted by the US chemical industry in 1988, and currently is practiced in 68 economies around the world.

There are 55 enlightened companies having Responsible Care (RC) logo in India, while a total of 148 companies are signatories to the programme, pursuing implementation of Codes of management practice.

Paushak is engaged in the manufacture of Phosgene & its derivatives. Phosgene is a versatile molecule and its derivatives have applications in diverse fields like pharmaceuticals, agrochemicals , polyurethanes, perfumeries, dyes, etc.

Paushak is currently trading at Rs. 2460.00, up by 10.00 points..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit110.2389.6
Gross Profit 142.8 489.9
Operating Profit 154.2428.5
Net Sales 3831395.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Elantas Beck India (BSE)
 2216.35 (2.57%)
M.Cap ( in Cr)
1757.05
Foseco India (BSE)
 960.10 (4.72%)
M.Cap ( in Cr)
613.16
Vinati Organics (BSE)
 804.65 (4.58%)
M.Cap ( in Cr)
8270.36
Keltech Energies (BSE)
 469.90 (5.95%)
M.Cap ( in Cr)
46.99
Aarti Inds (BSE)
 783.65 (2.86%)
M.Cap ( in Cr)
13653.88
Shareholding Pattern More
PROMOTERS 66.71 %
NON-INSTITUTION 33.28 %
FI/BANKS/INSURANCE 0.01 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes